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Abstract: LEOPARD syndrome (LS, OMIM 151100) is a rare monogenic disorder. The name is 
an acronym of its major features, including multiple lentigines, electrocardiographic 
conduction defects, ocular hypertelorism, pulmonary stenosis, abnormal genitalia, 
growth retardation and sensorineural deafness. LS develops due to mutations in the 
protein-tyrosine phosphatase nonreceptor-type 11 (PTPN11) gene. Here, we report a 
51-year-old Hungarian male patient affected by LS. Direct sequencing of the PTPN11 
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 gene revealed a worldwide recurrent missense mutation (c.836A/G; p.Tyr279Cys), 
which has been previously identified in 47 LS patients. Comparison of the clinical 
phenotypes of our patient and those reported in the literature revealed great 
phenotypic diversity, despite the shared genotype. 
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ABSTRACT 
1 
2 
3 
4 
5 LEOPARD syndrome (LS, OMIM 151100) is a rare monogenic disorder. The name is an 
6 
7 acronym of its major features such as multiple lentigines, electrocardiographic conduction 
8 
9 
defects, ocular hypertelorism, pulmonary stenosis, abnormalities of genitalia, retardation of 
11 
12 growth  and  sensorineural  deafness.  LS  develops  due  to  mutations  in  the protein-tyrosine 
13 
14 
phosphatase  nonreceptor-type  11,  PTPN11.  Here  we  have  investigated  a        51-year-old 
15 
16 
17 Hungarian male patient affected by LS. Direct sequencing of the PTPN11 gene revealed a 
18 
19 worldwide recurrent missense mutation (c.836A/G; p.Tyr279Cys), which has been previously 
20 
21 
22 identified in 47 LS patients. Comparison of the clinical phenotypes of our patient and the ones 
23 
24 reported  in  the  literature  demonstrates  great  phenotypic  diversity  despite  of  the      same 
25 
26 
genotype. 
28 
29 
30 
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INTRODUCTION 
1 
2 
3 
4 
5 LEOPARD syndrome (LS, OMIM 151100) - a rare monogenic disorder belonging to the 
6 
7 family  of  neuro-cardiofacio-cutaneous  syndromes   [16]  -  is  inherited  as  an      autosomal 
8 
9 
dominant trait with full penetrance and variable expressivity [3, 10]. The major features of LS 
11 
12 include multiple lentigines, electrocardiographic conduction abnormalities, ocular 
13 
14 
hypertelorism, pulmonary stenosis, abnormal genitalia, retardation of growth and 
15 
16 
17 sensorineural deafness, this is why the syndrome is referred with the LEOPARD acronym  [4, 
18 
19 10].  LS   develops  as  a  consequence  of  mutations  of  the  protein-tyrosine       phosphatase 
20 
21 
22 nonreceptor-type 11  (PTPN11) gene  encoding a cytoplasmic protein tyrosine     phosphatase 
23 
24 (SHP-2), which regulates intracellular signaling and controls several distinct developmental 
25 
26 
processes [15, 19]. In about 85% of the cases a heterozygous missense mutation is detected in 
28 
29 the exon 7, 12 or 13 [6, 11]. Among the so far identified missense mutations, there are two 
30 
31 
(p.Tyr279Cys and p.Thr468Met), which account for about 65% of all LS cases worldwide  [6, 
32 
33 
34 11]. 
35 
36 Here we report a Hungarian LS patient carrying the most common p.Tyr279Cys heterozygous 
37 
38 
39 missense  mutation  and  compare  his  clinical  features  with  the  symptoms  of     previously 
40 
41 reported LS patients (n=47), in whom the same causative mutation was identified. 
42 
43 
44 
45 
46 PATIENTS AND METHODS 
47 
48 
49 
50 
51 Patients 
52 
53 
A 51-year-old Hungarian male patient was admitted to the cardiology unit of the Orosháza 
54 
55 
56 Hospital  (Orosháza,  Hungary)  with  dizziness  and  palpitation.  On  investigation,       facial 
57 
58 anomalies including ocular hypertelorism, palpebral ptosis, dysmorphic ear, slight mandibular 
59 
60 
61 
62 
63 
64 
65 
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27 
 
prognathism (Fig 1a) and pigmentation abnormalities such as multiple lentigines (Fig 1b)  and 
1 
2 café-au-lait spots (Fig 1c) were also observed. Cardiology investigations revealed third degree 
3 
4 
5 atrioventricular block (Fig 1d). The patient is deaf and dumb since he was born and mild 
6 
7 growth as well as mental retardations were also present. Urological investigation revealed 
8 
9 
mild genital abnormalities such as atrophic testes. These clinical symptoms suggested LS, 
11 
12 therefore genetic screening of the PTPN11 gene was also performed. The patient was born out 
13 
14 
of wedlock, however the family members of his father and his mother were available for the 
15 
16 
17 clinical  and  genetic  investigations  (Fig  1e).  All  the  investigated  relatives  were clinically 
18 
19 unaffected suggesting the presence of a de novo mutation in the patient. 
20 
21 
22 
23 
24 Genetic investigations 
25 
26 
Blood sample was taken from the patient and genomic DNA has been isolated by a  BioRobot 
28 
29 EZ1 DSP  Workstation (Qiagen; Godollo, Hungary).  All the coding regions of the    PTPN11 
30 
31 
gene and the flanking introns were amplified and sequenced (primers were used as   displayed 
32 
33 
34 on the UCSC Genome Browser www.genome.ucsc.edu). The investigation was approved   by 
35 
36 the  Internal  Review  Board  of  the  University  of  Szeged.  Written  informed  consent   was 
37 
38 
39 obtained from the patient, and the study was conducted according to the Principles of the 
40 
41 Declaration of Helsinki. 
42 
43 
44 
45 
46 RESULTS 
47 
48 
49 
50 
51 Direct sequencing of the coding regions and the flanking introns of the PTPN11 gene revealed 
52 
53 
a heterozygous missense mutation (c.836A/G; p.Tyr279Cys) in the seventh exon (Fig 1f). The 
54 
55 
56 clinically affected  patient  carried  the  mutation  in  heterozygous  form,  while  the unrelated 
57 
58 healthy controls carried the wild type sequence (Fig 1g). 
59 
60 
61 
62 
63 
64 
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1 
2 DISCUSSION 
3 
4 
5 
6 
7 The investigated Hungarian  LS  patient  carries  one of the most  common missense  mutation 
8 
9 
(p.Tyr279Cys) of  the  PTPN11  gene. Functional  studies demonstrated  that the p.Tyr279Cys 
11 
12 heterozygous missense mutation of the PTPN11 gene perturbs the switching of the SHP-2 
13 
14 
protein between its catalytically inactive and active conformation and engenders loss of  SHP- 
15 
16 
17 2 catalytic activity [18]. 
18 
19 The p.Tyr279Cys mutation has previously been reported in 47 different LS patients with 
20 
21 
22 Italian, French, Spanish, German, Estonian,    Bosnian, Chinese Han, South-Korean, Japanese 
23 
24 and Australian origin [1, 5, 8, 9, 12, 13, 14, 17, 20, 21, 22]. Thus this missense mutation is a 
25 
26 
worldwide recurrent missense mutation. Among the reported LS cases there are ones with   de 
28 
29 novo mutation [9, 21] and others, in which the disease show familial clustering and affects 
30 
31 
multiple  family members  in  multiple  generations  [1,  5].  These  data  suggest  a mutational 
32 
33 
34 hotspot on the PTPN11 gene. 
35 
36 Previous  reports  demonstrated that  the p.Tyr279Cys  PTPN11  mutation  is  associated  with 
37 
38 
39 short stature, deafness and hypertrophic cardiomyopathy [6, 11], the detailed comparison of 
40 
41 the  clinical  symptoms  of  the  48  LS  patients  with  the  same  causative  mutation    further 
42 
43 
complicated the analysis of the genotype-phenotype correlations of this mutation. 
45 
46 The most common symptom, which was present in 46 (96%) out of 48 patients is the presence 
47 
48 
of multiple lentigines (Fig 2). Further skin abnormality such as the development of café-au- 
50 
51 lait  spots  were  observed  in  only  22  (46%)  patients.  Besides  the  characteristic   multiple 
52 
53 
lentigines, some of the facial anomalies were also very common among these patients:  ocular 
54 
55 
56 hypertelorism was detected in 40 (83%) patients, palpebral ptosis in 32 (67%) patients and 
57 
58 dysmorphic ears in 31 (65%) ones. Besides these common ectodermal abnormalities,  patients 
59 
60 
61 
62 
63 
64 
65 
6 
 
10 
27 
44 
49 
 
with  the  p.Tyr279Cys  PTPN11  mutation  have  a  great  chance  to  develop  cardiovascular 
1 
2 anomalies. Hypertrophic cardiomyopathy was diagnosed in 25 (52%) patients. Although short 
3 
4 
5 stature was previously reported to be frequently associated with the p.Tyr279Cys   phenotype, 
6 
7 it was present only in 19 (40%) patients out of 48. 
8 
9 
Regarding the other side of the spectrum, the p.Tyr279Cys mutation is rarely associated   with 
11 
12 deafness, which was reported in 12 (25%) patients (Fig 2). Moreover our analysis identified 
13 
14 
that certain symptoms - such as cryptorchidism, macrocephaly, horse kidney, hydrothorax, 
15 
16 
17 myelodysplasia and umbilical hernia - are rarely associated with the p.Tyr279Cys  phenotype. 
18 
19 In one of the 48 LS patients with the recurrent p.Tyr279Cys PTPN11 mutation, Marfan 
20 
21 
22 syndrome was also present, which is probably a rare independent association [17]. 
23 
24 The observed differences in the clinical symptoms of the 48 LS patients carrying the same 
25 
26 
missense  mutation  clearly  demonstrate  the  wide  phenotypic  diversity  and  the     variable 
28 
29 expressivity  of  the  disease.  In  general,  multiple  lentigines,  café-au-lait  macules,    ocular 
30 
31 
hypertelorism,   palpebral   ptosis,   dysmorphic   ears   and   hertrophic   cardiomyopathy   are 
32 
33 
34 hallmarks of the p.Tyr279Cys PTPN11 mutation related phenotype. However, there is no 
35 
36 similar analysis investigating the most frequently associated clinical features    in  LS  patients 
37 
38 
39 carrying the other common, recurrent missense mutation (p.Thr468Met) of the PTPN11 gene, 
40 
41 the published reports suggest that the p.Thr468Met mutation is also associated with high 
42 
43 
phenotypic diversity [2, 7]. 
45 
46 Further studies are needed to identify putative genetic, environmental or life style factors, 
47 
48 
which can modify the development of the clinical symptoms and responsible for the  observed 
50 
51 phenotypic diversity. The availability of the extended clinical findings about the p.Tyr279Cys 
52 
53 
mutation carriers, as provided by this study, is critical for promoting both our understanding 
54 
55 
56 of the disease and the development of causative therapies that will be more specific and 
57 
58 effective than the symptomatic treatments currently available for LS patients. 
59 
60 
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FIGURE LEGENDS 
1 
2 
3 
4 Fig. 1 The clinical symptoms, the pedigree of the patient and the identified recurrent 
5 
6 
mutation  of  the  PTPN11  gene.  On  examination  facial  dysmorphims  including     ocular 
7 
8 
9 hypertelorism, palpebral ptosis, slight mandibular prognathism and dysmorphic ears were 
10 
11 observed (Fig. 1a). Pigmentational abnormalities such as multiple lentigines (Fig. 1b) and 
12 
13 
14 café-au-lait spots (Fig. 1c) were also present on the patient skin. On electrocardiography a 
15 
16 third  degree  antrioventricular  block  was  present  (Fig.  1d).  The  patient  was  born outside 
17 
18 
19 marriage. The family members of his father and his mother were all clinically unaffected 
20 
21 individuals  suggesting   (Fig.  1e).  Direct  sequencing  revealed  a  heterozygous      missense 
22 
23 
mutation (c.836A/G; p.Tyr279Cys) in the seventh exon of the PTPN11 gene. The patient 
25 
26 carried the mutation in heterozygous form (Fig. 1f), while the unrelated controls carried the 
27 
28 
wild type sequence (Fig. 1g). 
29 
30 
31 
32 
33 Fig.  2  Comparison  of  the  frequency  of  the  different  symptoms  detected  in  the 
34 
35 
36 p.Tyr279Cys phenotype. The most common symptoms were the pigmentational 
37 
38 abnormalities   including   multiple  lentigines  and   café-au-lait   spots   and   the  mild  facial 
39 
40 
dysmorphisms such as ocular hypertelorism, palpebral ptosis and dysmorphic ears. In contrast 
42 
43 with  these,  cryptorchidism,  mental  retardation,  macrocephaly,  horse  kidney, hydrothorax, 
44 
45 
myelodysplasia and umbilical hernia were rarely associated with the p.Tyr279Cys phenotype. 
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